# Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus

> **NCT03760263** · PHASE4 · COMPLETED · sponsor: **Sentara Norfolk General Hospital** · enrollment: 46 (actual)

## Conditions studied

- Transplant;Failure,Kidney

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT03760263
- **Lead sponsor:** Sentara Norfolk General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-16
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-11-01
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-02-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03760263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03760263, "Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03760263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*